ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 759630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 759630; 2) Community: the network communities that were significantly associated with the response to NSC 759630; 3) Molecule: the relationships between components within communities and NSC 759630; 4) MDR: the compounds that were significantly associated with the NSC 759630.

NSC Compound Enrichment Correlation
NSC 731022 Null 0.0422011701988039 -0.19894971
NSC 735037 Camptothecin Derivative 0.0422011701988039 0.26378328
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0422011701988039 0.28435412
NSC 742629 Ethylenediaminetetraacetic acid bis-(5-amino salicylic acid methyl ester) 0.0422011701988039 0.34395762
NSC 750227 Null 0.0422011701988039 0.20146573
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0422011701988039 0.30806277
NSC 757387 ACRIFLAVINIUM HYDROCHLORIDE 0.0422011701988039 0.18156347
NSC 270057 Hydroxypristimerin 0.0438391811600409 0.15633601
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.0438391811600409 0.16916983
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0438391811600409 0.33328401
Total:54  Current:41    [First] [Prev] [Next] [Last]